Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Nov 11:2018:2703518.
doi: 10.1155/2018/2703518. eCollection 2018.

Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis

Affiliations
Meta-Analysis

Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis

Teeranan Angkananard et al. Biomed Res Int. .

Abstract

Objective: This systematic review aimed to measure the association between neutrophil lymphocyte ratio (NLR) and cardiovascular disease (CVD) risk.

Methods: Relevant studies were identified from Medline and Scopus databases. Observational studies with NLR as a study factor were eligible for review. The outcomes of interest were any type of CVD including acute coronary syndrome, coronary artery disease, stroke, or a composite of these cardiovascular events. Mean differences in NLR between CVD and non-CVD patients were pooled using unstandardized mean difference (USMD). Odds ratios of CVD between high and low NLR groups were pooled using a random effects model.

Results: Thirty-eight studies (n=76,002) were included. High NLR was significantly associated with the risks of CAD, ACS, stroke, and composite cardiovascular events with pooled ORs of 1.62 (95% CI: 1.38-1.91), 1.64 (95% CI: 1.30, 2.05), 2.36 (95% CI: 1.44, 2.89), and 3.86 (95% CI: 1.73, 8.64), respectively. In addition, mean NLRs in CAD, ACS, and stroke patients were significantly higher than in control groups.

Conclusion: High NLR was associated with CAD, ACS, stroke, and composite cardiovascular events. Therefore, NLR may be a useful CVD biomarker.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of study selection.
Figure 2
Figure 2
Summary of pooled effect sizes of neutrophil lymphocyte ratio on cardiovascular risk.

References

    1. All WHO fact sheets: Cardiovascular diseases (CVDs). Fact sheet number 317. 2017, http://www.who.int/mediacentre/factsheets/fs317/en/
    1. Top 10 Causes of Death. GBD Compare. 2016, http://viz.healthmetricsandevaluation.org/gbd-compare/
    1. Benjamin E. J., Blaha M. J., Chiuve S. E., et al. Circulation. The American Heart Association; 2017. Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association. - PMC - PubMed
    1. Hoffman M., Blum A., Baruch R., Kaplan E., Benjamin M. Leukocytes and coronary heart disease. Atherosclerosis. 2004;172(1):1–6. doi: 10.1016/s0021-9150(03)00164-3. - DOI - PubMed
    1. Venkatraghavan L., Tan T. P., Mehta J., Arekapudi A., Govindarajulu A., Siu E. Neutrophil Lymphocyte Ratio as a predictor of systemic inflammation - A cross-sectional study in a pre-admission setting. F1000Research. 2015;4 - PMC - PubMed

LinkOut - more resources